AbbVie Inc (ABBV)
Days of sales outstanding (DSO)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | |
DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days of sales outstanding (DSO) ratio for AbbVie Inc has been provided for the years ending December 31, 2020 to December 31, 2024. However, the data shows that the specific number of days for DSO is not available or has been masked. This lack of specific DSO values makes it challenging to analyze the trend or efficiency of AbbVie Inc in collecting its accounts receivable during these periods. Further details or actual DSO values would be required to assess the company's effectiveness in managing its receivables and cash flow.
Peer comparison
Dec 31, 2024
Company name
Symbol
DSO
AbbVie Inc
ABBV
—
Abbott Laboratories
ABT
—
ACADIA Pharmaceuticals Inc
ACAD
—
Alkermes Plc
ALKS
90.15
Amphastar P
AMPH
67.96
ANI Pharmaceuticals Inc
ANIP
—
Arcus Biosciences Inc
RCUS
7.07
Biomarin Pharmaceutical Inc
BMRN
84.73
Bristol-Myers Squibb Company
BMY
81.21
Catalyst Pharmaceuticals Inc
CPRX
—
Collegium Pharmaceutical Inc
COLL
—